Tenaya Therapeutics, Inc.
NASDAQ:TNYA
1.47 (USD) • At close January 15, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Operating Activities: | |||||
Net Income
| -124.084 | -123.665 | -72.721 | -38.395 | -26.231 |
Depreciation & Amortization
| 8.687 | 6.467 | 2.961 | 2.483 | 1.989 |
Deferred Income Tax
| 0 | 0 | 0.192 | 0.033 | -0.082 |
Stock Based Compensation
| 15.309 | 11.467 | 2.95 | 0.741 | 0.414 |
Change In Working Capital
| -5.648 | -0.849 | 4.742 | -0.234 | -0.25 |
Accounts Receivables
| 0 | 0 | 0 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 |
Accounts Payables
| -3.282 | 1.66 | 8.6 | 0.142 | 0.397 |
Other Working Capital
| -2.366 | -2.509 | -3.858 | -0.376 | -0.647 |
Other Non Cash Items
| 3.664 | 2.156 | 1.064 | -0.075 | 0.064 |
Operating Cash Flow
| -102.072 | -104.424 | -60.812 | -35.447 | -24.096 |
Investing Activities: | |||||
Investments In Property Plant And Equipment
| -1.239 | -20.63 | -25.121 | -9.763 | -2.926 |
Acquisitions Net
| 0 | 0 | 0 | 0 | 0.003 |
Purchases Of Investments
| -56.644 | -140.476 | -213.443 | 0 | -12.657 |
Sales Maturities Of Investments
| 106.623 | 244.75 | 0 | 2.753 | 10 |
Other Investing Activites
| -0.025 | 0.008 | -0.213 | 0.003 | -0.003 |
Investing Cash Flow
| 48.715 | 83.652 | -238.564 | -7.01 | -5.583 |
Financing Activities: | |||||
Debt Repayment
| 0 | 0 | 0 | 0 | 0 |
Common Stock Issued
| 3.868 | 77.387 | 188.541 | 0 | 0 |
Common Stock Repurchased
| 0 | 0 | -0.013 | -0.001 | -0.003 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| 0.181 | 0.38 | 20.442 | 147.269 | 30.514 |
Financing Cash Flow
| 4.049 | 77.767 | 208.97 | 147.268 | 30.511 |
Other Information: | |||||
Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 |
Net Change In Cash
| -49.308 | 56.995 | -90.406 | 104.811 | 0.832 |
Cash At End Of Period
| 46.363 | 95.671 | 38.676 | 129.082 | 24.271 |